Lukman Femi Owolabi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lukman Femi Owolabi has a total of 307 co-authors. Here are the top co-authors by number of shared publications:
Bappa Adamu
University of Bisha Medical College, Bisha, Saudi Arabia
11 shared publicationsAliyu Ibrahim
Department of Medicine, Bayero University, Kano, Nigeria
6 shared publications- Kolawole Wasiu Wahab
Department of Medicine, University of Ilorin & University of Ilorin Teaching Hospital , Ilorin
6 shared publications - Mayowa Ojo Owolabi
Center for Genomic and Precision Medicine, University of Ibadan, Nigeria
6 shared publications - Reginald Obiako
Neurology Unit, Department of Medicine, Ahmadu Bello University Teaching Hospital, Shika, Zaria, Nigeria
6 shared publications - Rufus Olusola Akinyemi
Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria
6 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 35 (11) , 108761
Stroke mortality continues to ravage Sub-Saharan Africa: a call to action
- 1 October 2026
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 35 (11) , 108761
Open AccessStroke mortality continues to ravage Sub-Saharan Africa: a call to action
- Open Access
- 25 August 2026
- Published by Elsevier in Equity Neuroscience
- Vol. 2 (3)
Perceived barriers to acute stroke care in Kano, Nigeria: A focus group study and literature review of Sub-Saharan African stroke care barriers
- 25 August 2026
- Published by Elsevier in Equity Neuroscience
- Vol. 2 (3)
Open AccessPerceived barriers to acute stroke care in Kano, Nigeria: A focus group study and literature review of Sub-Saharan African stroke care barriers
- Open Access
- 31 December 2025
- Published by LPPM Universitas 45 Mataram in Journal of Contemporary Islamic Law and Studies
- Vol. 1 (1) , 28-41
Beyond Legal Pluralism: Reframing the Dynamic Interaction between Shariah and State Law in Contemporary Muslim Societies
The discourse on legal pluralism has long been used to explain the coexistence of Shariah and state law in contemporary Muslim societies. However, existing approaches often remain descriptive, portraying this relationship as a static duality rather than a dynamic and evolving interaction. This study challenges conventional legal pluralism by proposing a reconceptualization of the relationship between Shariah and state law as a negotiated and adaptive legal interface shaped by socio-political, institutional, and epistemological forces. Employing a qualitative conceptual approach grounded in socio-legal theory and Islamic legal studies, this research develops a novel framework termed Dynamic Legal Interaction (DLI). The findings reveal that the interaction between Shariah and state law is not merely coexistence but a continuous process of translation, contestation, and integration, where authority is redistributed across religious institutions, state actors, and societal practices. This study advances a theoretical shift from pluralism as coexistence to pluralism as interactional governance, thereby offering a more nuanced understanding of legal hybridity in Muslim contexts. By reframing legal pluralism through a dynamic lens, this research contributes to global socio-legal scholarship and provides a transformative framework for analyzing the evolving role of Islamic law within modern state systems.
- 31 December 2025
- Published by LPPM Universitas 45 Mataram in Journal of Contemporary Islamic Law and Studies
- Vol. 1 (1) , 28-41
Open AccessBeyond Legal Pluralism: Reframing the Dynamic Interaction between Shariah and State Law in Contemporary Muslim Societies
The discourse on legal pluralism has long been used to explain the coexistence of Shariah and state law in contemporary Muslim societies. However, existing approaches often remain descriptive, portraying this relationship as a static duality rather than a dynamic and evolving interaction. This study challenges conventional legal pluralism by proposing a reconceptualization of the relationship between Shariah and state law as a negotiated and adaptive legal interface shaped by socio-political, institutional, and epistemological forces. Employing a qualitative conceptual approach grounded in socio-legal theory and Islamic legal studies, this research develops a novel framework termed Dynamic Legal Interaction (DLI). The findings reveal that the interaction between Shariah and state law is not merely coexistence but a continuous process of translation, contestation, and integration, where authority is redistributed across religious institutions, state actors, and societal practices. This study advances a theoretical shift from pluralism as coexistence to pluralism as interactional governance, thereby offering a more nuanced understanding of legal hybridity in Muslim contexts. By reframing legal pluralism through a dynamic lens, this research contributes to global socio-legal scholarship and provides a transformative framework for analyzing the evolving role of Islamic law within modern state systems.
- Open Access
Prevalence of epilepsy and the epilepsy treatment gap in Bauchi, Northeast Nigeria: a cross-sectional study of two communities
Objective: Epilepsy prevalence varies widely across Nigeria, with rates ranging from 3.1 to 37.0/1000 population. There have been no studies on epilepsy prevalence and treatment gap in the Northeast Region of Nigeria. This study aimed to study epilepsy prevalence and the epilepsy treatment gap (ETG) in an urban and a rural community in Northeast Nigeria. Design: Cross-sectional, community-based survey. Setting: Epilepsy screening of residents in two communities in Northeast Nigeria using a WHO screening tool and a validated study questionnaire from 1 March to 10 June 2022. Participants: 8599 community residents aged ≥2 years. Outcome measures: Prevalence of epilepsy, active epilepsy, ETG and associated factors. Results: We screened 8599 residents, of whom 88 had epilepsy. Crude epilepsy prevalence was 10.2 per 1000 and was three times higher in the rural than in the urban community (18.5 vs 6.4; χ 2 =26.79, p2 =0.087, p=0.768). Logistic regression analysis showed that the ETG was associated with a lack of counselling (OR 15.8, 95% CI 3.5 to 70.7, p<0.001) but not a prior diagnosis of epilepsy, sex, age, marital status, urban versus rural residence or distance to the health centre ≥2 versus <2 km. Among 20 participants with epilepsy, electroencephalography suggested focal epilepsy in four participants, generalised epilepsy in eight and normal findings in eight, while brain CT scans in six participants were all normal. Conclusion: The prevalence of epilepsy in Bauchi State was within the range reported in Nigeria but three times higher in the rural than in the urban community. A high ETG was associated with poor counselling of people with epilepsy. Epilepsy counselling, health education and wider access to neurology services could reduce the burden of epilepsy in Northeast Nigeria.
Open AccessPrevalence of epilepsy and the epilepsy treatment gap in Bauchi, Northeast Nigeria: a cross-sectional study of two communities
Objective: Epilepsy prevalence varies widely across Nigeria, with rates ranging from 3.1 to 37.0/1000 population. There have been no studies on epilepsy prevalence and treatment gap in the Northeast Region of Nigeria. This study aimed to study epilepsy prevalence and the epilepsy treatment gap (ETG) in an urban and a rural community in Northeast Nigeria. Design: Cross-sectional, community-based survey. Setting: Epilepsy screening of residents in two communities in Northeast Nigeria using a WHO screening tool and a validated study questionnaire from 1 March to 10 June 2022. Participants: 8599 community residents aged ≥2 years. Outcome measures: Prevalence of epilepsy, active epilepsy, ETG and associated factors. Results: We screened 8599 residents, of whom 88 had epilepsy. Crude epilepsy prevalence was 10.2 per 1000 and was three times higher in the rural than in the urban community (18.5 vs 6.4; χ 2 =26.79, p2 =0.087, p=0.768). Logistic regression analysis showed that the ETG was associated with a lack of counselling (OR 15.8, 95% CI 3.5 to 70.7, p<0.001) but not a prior diagnosis of epilepsy, sex, age, marital status, urban versus rural residence or distance to the health centre ≥2 versus <2 km. Among 20 participants with epilepsy, electroencephalography suggested focal epilepsy in four participants, generalised epilepsy in eight and normal findings in eight, while brain CT scans in six participants were all normal. Conclusion: The prevalence of epilepsy in Bauchi State was within the range reported in Nigeria but three times higher in the rural than in the urban community. A high ETG was associated with poor counselling of people with epilepsy. Epilepsy counselling, health education and wider access to neurology services could reduce the burden of epilepsy in Northeast Nigeria.
- Open Access
- 14 June 2025
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (8) , 108378
Communicating the ethical, legal, and social issues in neurobiobanking and stroke genomic research in Africa: Project intervention tools development and evaluation procedures
- 14 June 2025
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (8) , 108378
Open AccessCommunicating the ethical, legal, and social issues in neurobiobanking and stroke genomic research in Africa: Project intervention tools development and evaluation procedures
- Open Access
Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations
Elucidating the genetic contributions to Parkinson’s disease (PD) etiology across diverse ancestries is a critical priority for the development of targeted therapies in a global context. We conducted the largest sequencing characterization of potentially disease-causing, protein-altering and splicing mutations in 710 cases and 11,827 controls from genetically predicted African or African admixed ancestries. We explored copy number variants (CNVs) and runs of homozygosity (ROHs) in prioritized early onset and familial cases. Our study identified rare GBA1 coding variants to be the most frequent mutations among PD patients, with a frequency of 4% in our case cohort. Out of the 18 GBA1 variants identified, ten were previously classified as pathogenic or likely pathogenic, four were novel, and four were reported as of uncertain clinical significance. The most common known disease-associated GBA1 variants in the Ashkenazi Jewish and European populations, p.Asn409Ser, p.Leu483Pro, p.Thr408Met, and p.Glu365Lys, were not identified among the screened PD cases of African and African admixed ancestry. Similarly, the European and Asian LRRK2 disease-causing mutational spectrum, including LRRK2 p.Gly2019Ser and p.Gly2385Arg genetic risk factors, did not appear to play a major role in PD etiology among West African-ancestry populations. However, we found three heterozygous novel missense LRRK2 variants of uncertain significance overrepresented in cases, two of which — p.Glu268Ala and p.Arg1538Cys — had a higher prevalence in the African ancestry population reference datasets. Structural variant analyses revealed the presence of PRKN CNVs with a frequency of 0.7% in African and African admixed cases, with 66% of CNVs detected being compound heterozygous or homozygous in early-onset cases, providing further insights into the genetic underpinnings in early-onset juvenile PD in these populations. Novel genetic variation overrepresented in cases versus controls among screened genes warrants further replication and functional prioritization to unravel their pathogenic potential. Here, we created the most comprehensive genetic catalog of both known and novel coding and splicing variants potentially linked to PD etiology in an underserved population. Our study has the potential to guide the development of targeted therapies in the emerging era of precision medicine. By expanding genetics research to involve underrepresented populations, we hope that future PD treatments are not only effective but also inclusive, addressing the needs of diverse ancestral groups.
Open AccessLarge-scale genetic characterization of Parkinson’s disease in the African and African admixed populations
Elucidating the genetic contributions to Parkinson’s disease (PD) etiology across diverse ancestries is a critical priority for the development of targeted therapies in a global context. We conducted the largest sequencing characterization of potentially disease-causing, protein-altering and splicing mutations in 710 cases and 11,827 controls from genetically predicted African or African admixed ancestries. We explored copy number variants (CNVs) and runs of homozygosity (ROHs) in prioritized early onset and familial cases. Our study identified rare GBA1 coding variants to be the most frequent mutations among PD patients, with a frequency of 4% in our case cohort. Out of the 18 GBA1 variants identified, ten were previously classified as pathogenic or likely pathogenic, four were novel, and four were reported as of uncertain clinical significance. The most common known disease-associated GBA1 variants in the Ashkenazi Jewish and European populations, p.Asn409Ser, p.Leu483Pro, p.Thr408Met, and p.Glu365Lys, were not identified among the screened PD cases of African and African admixed ancestry. Similarly, the European and Asian LRRK2 disease-causing mutational spectrum, including LRRK2 p.Gly2019Ser and p.Gly2385Arg genetic risk factors, did not appear to play a major role in PD etiology among West African-ancestry populations. However, we found three heterozygous novel missense LRRK2 variants of uncertain significance overrepresented in cases, two of which — p.Glu268Ala and p.Arg1538Cys — had a higher prevalence in the African ancestry population reference datasets. Structural variant analyses revealed the presence of PRKN CNVs with a frequency of 0.7% in African and African admixed cases, with 66% of CNVs detected being compound heterozygous or homozygous in early-onset cases, providing further insights into the genetic underpinnings in early-onset juvenile PD in these populations. Novel genetic variation overrepresented in cases versus controls among screened genes warrants further replication and functional prioritization to unravel their pathogenic potential. Here, we created the most comprehensive genetic catalog of both known and novel coding and splicing variants potentially linked to PD etiology in an underserved population. Our study has the potential to guide the development of targeted therapies in the emerging era of precision medicine. By expanding genetics research to involve underrepresented populations, we hope that future PD treatments are not only effective but also inclusive, addressing the needs of diverse ancestral groups.
- Open Access
- 29 March 2023
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 32 (4) , 107012
DETERMINANTS OF STROKE MORTALITY AMONG WEST AFRICANS: FINDINGS FROM THE SIREN STUDY
- 29 March 2023
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 32 (4) , 107012
Open AccessDETERMINANTS OF STROKE MORTALITY AMONG WEST AFRICANS: FINDINGS FROM THE SIREN STUDY
- Open Access
- 2 November 2022
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 22 (1) , 1-12
Magnitude of diabetic peripheral neuropathy in Saudi Arabia: a systematic review and meta-analysis
Background: Diabetic peripheral neuropathy (DPN), due to its potential for causing morbidity and disability from foot ulcers and amputations, is increasingly becoming a source of concern in Saudi Arabia and worldwide. However, wide variability exists in the prevalence of DPN reported in previous studies in Saudi Arabia, limiting the utility of existing data in national public health policy. Therefore, the aim of this study was to systematically evaluate the magnitude of DPN in patients living with DM in Saudi Arabia in order to inform policymakers during the implementation of appropriate preventive and treatment strategies for DPN.Methods: PubMed, Google Scholar, African Journals Online, Scopus, Web of Science, Embase, and Wiley Online Library were searched systematically to acquire relevant articles based on preset criteria. We evaluated heterogeneity and publication bias and employed a random-effects model to estimate the pooled prevalence of DPN from the included studies. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines in conducting the meta-analysis. Analysis was performed using the STATA Version 12 software.Results: Twelve studies with a total of 4,556 participants living with DM, of whom 2,081 were identified as having DPN were included in the meta-analysis. The overall prevalence of DPN was 39% (95% CI [30%, 49%]). Subgroup analysis based on diagnostic method showed that prevalence estimates for DPN using screening questionnaires and clinical examination were 48% (95% CI [46%, 50%]) and 40% (95% CI: [38%, 42%]), respectively, while the estimated prevalence using nerve conduction studies was 26% (95% CI [15%, 36%]).Conclusion: This study showed a high magnitude of DPN in Saudi Arabia (39%), thus highlighting the need for sustained efforts to reduce the prevalence of diabetes mellitus and DPN in the kingdom.
- 2 November 2022
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 22 (1) , 1-12
Open AccessMagnitude of diabetic peripheral neuropathy in Saudi Arabia: a systematic review and meta-analysis
Background: Diabetic peripheral neuropathy (DPN), due to its potential for causing morbidity and disability from foot ulcers and amputations, is increasingly becoming a source of concern in Saudi Arabia and worldwide. However, wide variability exists in the prevalence of DPN reported in previous studies in Saudi Arabia, limiting the utility of existing data in national public health policy. Therefore, the aim of this study was to systematically evaluate the magnitude of DPN in patients living with DM in Saudi Arabia in order to inform policymakers during the implementation of appropriate preventive and treatment strategies for DPN.Methods: PubMed, Google Scholar, African Journals Online, Scopus, Web of Science, Embase, and Wiley Online Library were searched systematically to acquire relevant articles based on preset criteria. We evaluated heterogeneity and publication bias and employed a random-effects model to estimate the pooled prevalence of DPN from the included studies. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines in conducting the meta-analysis. Analysis was performed using the STATA Version 12 software.Results: Twelve studies with a total of 4,556 participants living with DM, of whom 2,081 were identified as having DPN were included in the meta-analysis. The overall prevalence of DPN was 39% (95% CI [30%, 49%]). Subgroup analysis based on diagnostic method showed that prevalence estimates for DPN using screening questionnaires and clinical examination were 48% (95% CI [46%, 50%]) and 40% (95% CI: [38%, 42%]), respectively, while the estimated prevalence using nerve conduction studies was 26% (95% CI [15%, 36%]).Conclusion: This study showed a high magnitude of DPN in Saudi Arabia (39%), thus highlighting the need for sustained efforts to reduce the prevalence of diabetes mellitus and DPN in the kingdom.
- Open Access
- 12 April 2022
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 43 (4) , 408-417
Disease-specific quality of life in patients with diabetic neuropathy
Objectives: To compare health-related quality of life (HRQoL) among patients with diabetes mellitus (DM) and diabetic neuropathy (DN) (D+N) with patients with DM without DN (D-DN) and healthy participants. To evaluate factors associated with poor HRQoL in patients with DN. Methods: This study included 306 participants residing in Bisha, Saudi Arabia. Patients with DM were screened for DN using the Michigan Neuropathy Screening Instrument. Neuropathy severity, disability and HRQoL were determined using the Neuropathy Severity Scale (NSS), the Neuropathy Disability Score (NDS), and the Norfolk Quality of Life-Diabetic Neuropathy (QOL-DN) tool, respectively. Nerve conduction studies (NCSs) were also performed. Results: The D+DN group had poorer overall and domain HRQoL scores compared to the D-DN group (pppp=0.043), duration of DM (ppp<0.0001) predicted HRQoL in the D+DN group. Conclusion: D+DN participants had a worse HRQoL compared with D-DN and healthy counterparts. NDS, NNS, physical inactivity, abnormal NCS, and duration of DM independently predicted poor HRQoL in D+DN participants.
- 12 April 2022
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 43 (4) , 408-417
Open AccessDisease-specific quality of life in patients with diabetic neuropathy
Objectives: To compare health-related quality of life (HRQoL) among patients with diabetes mellitus (DM) and diabetic neuropathy (DN) (D+N) with patients with DM without DN (D-DN) and healthy participants. To evaluate factors associated with poor HRQoL in patients with DN. Methods: This study included 306 participants residing in Bisha, Saudi Arabia. Patients with DM were screened for DN using the Michigan Neuropathy Screening Instrument. Neuropathy severity, disability and HRQoL were determined using the Neuropathy Severity Scale (NSS), the Neuropathy Disability Score (NDS), and the Norfolk Quality of Life-Diabetic Neuropathy (QOL-DN) tool, respectively. Nerve conduction studies (NCSs) were also performed. Results: The D+DN group had poorer overall and domain HRQoL scores compared to the D-DN group (pppp=0.043), duration of DM (ppp<0.0001) predicted HRQoL in the D+DN group. Conclusion: D+DN participants had a worse HRQoL compared with D-DN and healthy counterparts. NDS, NNS, physical inactivity, abnormal NCS, and duration of DM independently predicted poor HRQoL in D+DN participants.
- 19 March 2022
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 31 (4) , 106362
CORRELATION BETWEEN SERUM LOW DENSITY LIPOPROTEIN (LDL) LEVELS AND HEMORRHAGIC STROKE SEVERITY: A RETROSPECTIVE REVIEW (PRELIMINARY FINDINGS)
- 19 March 2022
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 31 (4) , 106362
CORRELATION BETWEEN SERUM LOW DENSITY LIPOPROTEIN (LDL) LEVELS AND HEMORRHAGIC STROKE SEVERITY: A RETROSPECTIVE REVIEW (PRELIMINARY FINDINGS)